Rate limiting factors in recruitment of patients to clinical trials in cancer research: Descriptive study

British Medical Journal

Volumn 327, Issue 7410, 2003, Pages 320-321

  Corrie, Pippa ^a   Shaw, Justin ^a   Harris, Roy ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; DATA BASE; FINANCIAL MANAGEMENT; INFORMATION RETRIEVAL; MEDICAL INFORMATION SYSTEM; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TOTAL QUALITY MANAGEMENT;

EID: 0042634391     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7410.320     Document Type: Article

References (4)

1. National Cancer Research Institute. Strategic analysis. An overview of cancer research in the UK directly funded by the NCRI partner organisations. London: NCRI, October 2002.
2. Kmietowicz Z. Research spending on cancers doesn't match their death rates. BMJ 2001;325:920.
3. Baum M. The ATAC (arimidex, tamoxifen, alone or in combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment. Eur J Cancer 2002;38:1684-6.
4. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-5.